
Steve Harr
individual
About
Steve Harr, M.D., is co-founder, President, and Chief Executive Officer of Sana Biotechnology, a cell and gene engineering company. Before Sana, he was Chief Financial Officer and Head of Corporate Development at Juno Therapeutics and earlier spent 12 years at Morgan Stanley, including as Managing Director and Head of Biotechnology Investment Banking. Sana's official bio also notes prior board roles at Loxo Oncology and JW Therapeutics.
Areas of interest
biotechcell therapygene therapygene editingimmunologyoncologytype 1 diabetesregenerative medicinecorporate finance